Donald Olds, Chief Operating Officer, Telesta Therapeutics Inc., Telephone: (514) 394-7921, Donald.Olds@telestatherapeutics.comCopyright CNW Group 2015
Telesta Therapeutics Appoints Brian J. Groch as Chief Commercial Officer
View original source (CNW)Telesta Therapeutics Inc on 6ix
Earlier from Telesta Therapeutics
- Telesta Announces FDA Advisory Committee Date for MCNA1
- Telesta Therapeutics Publishes its Annual Consolidated Financial Statements and Provides Corporate Updates
- Telesta Receives FDA BLA Filing Notification Letter and Priority Review Designation for MCNA(1)
- Telesta Therapeutics Closes US$28.6 Million Private Placement
- Telesta Therapeutics Announces South Korean Partnership for MCNA & Concurrent Private Placement
Later from Telesta Therapeutics
- Telesta Therapeutics and Ipsen announce exclusive license agreement for MCNA(1) for the treatment of non-muscle invasive bladder cancer in major ex-United States territories
- Telesta Therapeutics Publishes its Q1, 2016 Financial Statements and Provides Corporate Updates
- Telesta Therapeutics Inc. Announces Results of Annual General Meeting of Shareholders
- Telesta Therapeutics Announces Results of the FDA Advisory Committee Vote
- Telesta Therapeutics Corporate Update
Follow Telesta Therapeutics into a list and get an email when it puts out news.
Follow Telesta Therapeutics